Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna K. Zoellner"'
Autor:
Myriam Labopin, Matthias Stelljes, Boris V. Afanasyev, Sebastian Giebel, Anna K. Zoellner, Gernot Stuhler, Mohamad Mohty, Renato Fanin, Jiří Pavlů, Adrian Bloor, Ioanna Sakellari, Arnon Nagler, Jürgen Finke, Achilles Anagnostopoulos
Publikováno v:
Cancer. 123:1965-1970
BACKGROUND: Patients with primary refractory acute lymphoblastic leukemia (PREF ALL) who fail to achieve a complete remission (CR) after >= 2 courses of chemotherapy have a dismal prognosis without undergoing allogeneic hematopoietic cell transplanta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfa604e5f2bc3cd1ae998b73cf55c393
https://doi.org/10.1002/cncr.30604
https://doi.org/10.1002/cncr.30604
Autor:
Susanne Fritsch, Veit Bücklein, Georg Ledderose, Anna-K. Zoellner, Johanna Tischer, Roland Reibke, Wolfgang Hill, Hans Joachim Stemmler, Christina Rieger, Dusan Prevalsek, Thomas Köhnke, Gundula Jäger, Christoph Schulz, Friederike Mumm, Nicole Engel, Max Hubmann, Christoph Schmid, Andreas Hausmann, Hans-Jochem Kolb, Andreas Moosmann
Publikováno v:
Annals of Hematology. 94:1677-1688
We retrospectively compared the incidence of virus infections and outcome in the context of immune reconstitution in two different HLA-haploidentical transplantation (haplo-HSCT) settings. The first was a combined T-cell-replete and T-cell-deplete ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c1ed82e440348a3d5666232e594fecc
https://doi.org/10.1007/s00277-015-2423-y
https://doi.org/10.1007/s00277-015-2423-y
Autor:
Johanna Tischer, Christoph Schulz, Nicole Engel, Wolfgang Hill, Anna K. Zoellner, Georg Ledderose, Dusan Prevalsek, Andreas Hausmann, Veit Bücklein, Max Hubmann, Hans Joachim Stemmler, Susanne Fritsch
Publikováno v:
Annals of Hematology. 92:1379-1388
Clofarabine is a novel purine nucleoside analogue with immunosuppressive and anti-leukemic activity in acute lymphoblastic and myeloid leukemia (AML, ALL). This retrospective study was performed to evaluate the feasibility and anti-leukemic activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82f37236f21f8668b2fdafb1d17e47b
https://doi.org/10.1007/s00277-013-1862-6
https://doi.org/10.1007/s00277-013-1862-6
Autor:
Jiří, Pavlů, Myriam, Labopin, Anna K, Zoellner, Ioanna, Sakellari, Matthias, Stelljes, Jürgen, Finke, Renato, Fanin, Gernot, Stuhler, Boris V, Afanasyev, Adrian J, Bloor, Achilles, Anagnostopoulos, Mohamad, Mohty, Sebastian, Giebel, Arnon, Nagler
Publikováno v:
Cancer. 123(11)
Patients with primary refractory acute lymphoblastic leukemia (PREF ALL) who fail to achieve a complete remission (CR) after ≥2 courses of chemotherapy have a dismal prognosis without undergoing allogeneic hematopoietic cell transplantation (HCT).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3eb1fcadadd6cbfaf55308aa8904783f
https://pubmed.ncbi.nlm.nih.gov/28211939
https://pubmed.ncbi.nlm.nih.gov/28211939